The ARRIVE Trial of Daily Aspirin Does Not Demonstrate Lower Risk of First Cardiovascular Event

Study of aspirin as a primary prevention for cardiovascular events reports fewer events than expected for overall study population
Source: BWH News - Category: Hospital Management Source Type: news